ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

SANOFI SA INHABER EO 2/  FR0000120578  /

TradeGate
27.12.2024  21:31:12 Изменение +0.560 Объем сделки Бид21:59:59 Предложение21:59:59 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
93.420EUR +0.60% 4,774
Оборот: 441,275.960		 93.190Величина цены спроса: 110 93.380Величина цены предложения: 110 116.94 млрдEUR 4.03% 21.64
TeleTrader 22.11 Europe closes higher, FTSE up over 1%
TeleTrader 25.10 Europe closes mixed amid earnings, data
TeleTrader 25.10 Europe lower in premarket as financial results pour in
TeleTrader 25.10 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 21.10 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 02.09 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 26.08 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 14.08 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13.08 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 12.08 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 12.08 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 08.08 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 07.08 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 06.08 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 05.08 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 02.08 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 01.08 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 01.08 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 31.07 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 25.07 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 25.07 Europe lower premarket as earnings pour in
TeleTrader 25.07 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 25.07 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 24.07 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 18.07 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...